4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-025768
COO and Secretary sold 10,000 shares at an average $56.09 ($560,901)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…